Daily non-political popular news in brief.
Drug based on MGH discovery may significantly improve treatment of dangerous blood disorder
01-31-2008 · EurekAlert!Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of the Lancet.
Read more »
Keywords: drug, based, mgh, discovery, significantly, improve, treatment, dangerous, blood, disorder, dangerou
« Previous | Next »
Similar news on "Drug based on MGH discovery may significantly improve treatment of dangerous blood disorder":
- Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder
01-31-2008 · EurekAlert!
Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of The Lancet.
Similar news · Read more »
- Mayo Clinic study indicates medication for ADHD may help student outcomes
09-18-2007 · EurekAlert!
In an 18-year-study on attention-deficit/hyperactivity disorder, Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD. The Mayo Clinic results are the first population-based data to show stimulant drug therapy helps improve long-term school outcomes.
Similar news · Read more »
- Radiation and drug combo helps boost efficacy of lung-cancer treatment
09-04-2007 · UT Southwestern Medical Center
Combining radiation therapy with a drug that helps destroy blood vessels nourishing malignant tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone, researchers at UT Southwestern Medical Center have found.
Similar news · Read more »
- Drug used for treatment for heart failure in adults may not be beneficial for children and teens
09-11-2007 · EurekAlert!
Preliminary findings indicate a heart failure medication used by adults, carvedilol, may not significantly improve heart failure outcomes for children and adolescents, according to an article in the Sept. 12 issue of JAMA.
Similar news · Read more »
- Eculizumab is well-tolerated and shows significant improvement in PNH patients (Ph III)
12-09-2006 · EurekAlert!
Eculizumab, a MAb drug, appeared safe and well-tolerated, and provided clinically and statistically significant improvements in intravascular hemolysis, anemia, fatigue and quality of life in patients with paroxysmal nocturnal hemoglobinuria (PNH) in a Phase 3 open-label, 52 weeks of treatment trial. PNH is a rare and life-threatening form of hemolytic anemia and acquired genetic blood disorder, and patients lack naturally-occurring complement inhibitors on the surface of their red blood cells.
Similar news · Read more »
- Eltrombopag effective for hepatitis C patients with low blood-platelet counts
12-28-2007 · EurekAlert!
For patients with hepatitis C, having a low blood platelet count is a frequent complication associated with advanced disease. This problem is compounded by the fact that standard antiviral treatment for the disease can further reduce platelet numbers to dangerously low levels, effectively denying these patients the treatment they urgently need. Now, research published in the New England Journal of Medicine finds that a new drug, eltrombopag, appears to significantly boost platelet counts, opening the door to effective treatment.
Similar news · Read more »
- Study finds drug helps PTSD nightmares
04-11-2007 · EurekAlert!
A generic drug already used by millions of Americans for high blood pressure and prostate problems has been found to improve sleep and lessen trauma nightmares in veterans with posttraumatic stress disorder (PTSD).
Similar news · Read more »
- A faster way to recover from chemotherapy and marrow transplant
06-20-2007 · EurekAlert!
Researchers at Children's Hospital Boston report finding a practical way to increase stem cells in blood, suggesting a possible treatment to help patients recover from chemotherapy or bone marrow transplant for cancer, regaining immune function more quickly. The discovery, reported in the June 21 Nature and made possible through high-volume drug screening in fish, marks the first time stem-cell production has been induced by a small-molecule drug.
Similar news · Read more »
- Microchip-based device can detect rare tumor cells in bloodstream
12-19-2007 · EurekAlert!
A team of investigators from the Massachusetts General Hospital BioMEMS Resource Center and the MGH Cancer Center has developed a microchip-based device that can isolate, enumerate and analyze circulating tumor cells from a blood sample. The new device -- called the "CTC-chip," -- has the potential to be an invaluable tool for monitoring and guiding cancer treatment.
Similar news · Read more »
- Longer treatment benefits sleep apnea patients
06-06-2007 · EurekAlert!
Adults with obstructive sleep apnea benefit significantly from longer nightly use of continuous positive airway pressure (CPAP), a device to improve breathing during sleep, according to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. This is the first study to identify the nightly duration of CPAP use needed to gain maximum benefit for daytime alertness and functioning.
Similar news · Read more »
